Skip to main content
Premium Trial:

Request an Annual Quote

GenVault Raises $1.5M in VC Financing

This article has been updated from a previous version to clarify the fact that the current financing is part of the same round that the company raised in April.
NEW YORK (GenomeWeb News) — GenVault said today it has received $1.5 million in venture capital financing to help it develop and market its DNA-preservation technology.
GenVault’s platform is used to extract, preserve, recover, and distribute DNA at room temperature. The company also said it expects future storage systems to accommodate proteins and RNA.
The financing is part of an $18 million round GenVault raised in April from Domain Associates and QuestMark Partners, bringing the total funding raised in the round to $19.5 million.
The additional financing is from Cross Creek Capital, a private equity affiliate of Wasatch Advisors.
Karey Barker, Cross Creek’s managing director, said GenVault “presented investors with an unusual and timely opportunity to participate at the nexus of several new, diverse industries that rely on careful management and archiving of gene-related materials.”

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.